Biotech Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Etedesiran (AOC 1001) for Treatment of Myotonic Dystrophy Type 1 May 8, 2024
Biotech NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investments from Celadon Partners and ClavystBio May 8, 2024
Biotech IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update May 7, 2024
Biotech Capsida Biotherapeutics Presents New Preclinical Evidence Indicating Novel First-in-Class IV-Administered Gene Therapy Effectively Treats Genetic Epilepsy Due to STXBP1 Mutations May 7, 2024
Biotech Selvita completes acquisition of PozLab and significantly expands its drug development capabilities May 7, 2024
Biotech Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024 May 7, 2024
Biotech 21st.BIO unveils a new pilot plant facility to accelerate impact of biotech innovations globally May 6, 2024